| Application no. and date | 16852340.5 (espacenet) (Federated) (European Patent Register), 20160923 | | Patent/reg. no. and date | DK/EP 3355889, 20230215 | | Publication date | 20180808 | | Priority no. and date | US 201562234584 P, 20150929, US 201662336381 P, 20160513 | | EP pub. no. and date |
EP 3355889 20180808 | | Effective date | | | Applicant/owner | Afferent Pharmaceuticals Inc., 126 East Lincoln Avenue
Rahway
New Jersey 07065, US | | Applicant ref. no. | PU277985DKQ | | Inventor | FORD, Anthony, P., 2929 Campus Drive
Suite 230
San Mateo, California 94403, US,
GLAUB, Kathleen Sereda, 2929 Campus Drive
Suite 230
San Mateo, California 94403, US,
KITT, Michael, M., 2929 Campus Drive
Suite 230
San Mateo, California 94403, US,
SMITH, Steven, 2929 Campus Drive
Suite 230
San Mateo, California 94403, US | | Representative | Marks & Clerk LLP, 44, rue de la Vallée
L-2661 Luxembourg, LU | | Opponent | | | IPC Class | A61K 31/505 (2006.01) , A61K 45/06 (2006.01) , A61K 47/38 (2006.01) , A61K 47/44 (2017.01) , A61K 9/00 (2006.01) , A61K 9/06 (2006.01) , A61K 9/10 (2006.01) , A61K 9/20 (2006.01) , A61K 9/48 (2006.01) , A61P 11/14 (2006.01) , A61P 43/00 (2006.01) | | Title | DIAMINOPYRIMIDIN-P2X3- OG P2X2/3-RECEPTORMODULATORER TIL ANVENDELSE I
BEHANDLING AF HOSTE | | Int. application no. | US2016053223 | | Int. publication no. | WO2017058645 | | Related patent (certificate) | CA 2024 00008 | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
